Moors & Cabot’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $952K | Sell |
|
|||||
|
2025
Q1 | $987K | Sell |
|
|||||
|
2024
Q4 | $900K | Sell |
|
|||||
|
2024
Q3 | $1.1M | Sell |
|
|||||
|
2024
Q2 | $1.05M | Buy |
|
|||||
|
2024
Q1 | $1.1M | Sell |
|
|||||
|
2023
Q4 | $999K | Sell |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.1M | Sell |
|
|||||
|
2022
Q3 | $922K | Sell |
|
|||||
|
2022
Q2 | $1.94M | Sell |
|
|||||
|
2022
Q1 | $1.95M | Buy |
|
|||||
|
2021
Q4 | $1.93M | Buy |
|
|||||
|
2021
Q3 | $1.6M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Buy |
|
|||||
|
2021
Q1 | $1.23M | Sell |
|
|||||
|
2020
Q4 | $1.31M | Sell |
|
|||||
|
2020
Q3 | $1.41M | Buy |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $1.83M | Sell |
|
|||||
|
2019
Q3 | $1.7M | Buy |
|
|||||
|
2019
Q2 | $1.56M | Buy |
|
|||||
|
2019
Q1 | $1.62M | Sell |
|
|||||
|
2018
Q4 | $1.56M | Sell |
|
|||||
|
2018
Q3 | $1.82M | Sell |
|
|||||
|
2018
Q2 | $1.84M | Sell |
|
|||||
|
2018
Q1 | $1.81M | Buy |
|
|||||
|
2017
Q4 | $1.16M | Sell |
|
|||||
|
2017
Q3 | $1.67M | Sell |
|
|||||
|
2017
Q2 | $1.9M | Sell |
|
|||||
|
2017
Q1 | $1.87M | Sell |
|
|||||
|
2016
Q4 | $1.75M | Buy |
|
|||||
|
2016
Q3 | $1.9M | Buy |
|
|||||
|
2016
Q2 | $1.82M | Buy |
|
|||||
|
2016
Q1 | $1.27M | Buy |
|
|||||
|
2015
Q4 | $1.11M | Sell |
|
|||||
|
2015
Q3 | $1.14M | Sell |
|
|||||
|
2015
Q2 | $1.52M | Sell |
|
|||||
|
2015
Q1 | $2.12M | Buy |
|
|||||
|
2014
Q4 | $1.91M | Buy |
|
|||||
|
2014
Q3 | $1.97M | Buy |
|
|||||
|
2014
Q2 | $1.09M | Buy |
|
|||||
|
2014
Q1 | $1.06M | Buy |
|